$0.3008
-0.005-1.64%
Last update: Aug 25, 3:28 PM
GT Biopharma Inc (GTBP) Stock Price, Quote, News & History
GTBPNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy GT Biopharma (GTBP) stock?
You can purchase shares of GT Biopharma (NASDAQ:GTBP) through any online brokerage.
Who are GT Biopharma (GTBP) competitors?
Other companies in GT Biopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for GT Biopharma (GTBP) stock?
GT Biopharma has a consensus price target of $11.00.
What is the current price for GT Biopharma (GTBP)?
The stock price for GT Biopharma (NASDAQ: GTBP) is $0.3008 last updated August 25, 2026 at 3:28 PM EDT.
Does GT Biopharma (GTBP) pay a dividend?
There are no upcoming dividends for GT Biopharma.
When is GT Biopharma (NASDAQ:GTBP) reporting earnings?
GT Biopharma does not have any upcoming earnings scheduled.
Is GT Biopharma (GTBP) going to split?
There is no upcoming split for GT Biopharma.
What sector and industry does GT Biopharma (GTBP) operate in?
GT Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
